Advanced Relapsed Clear Cell Renal Cell Carcinoma clinical trials

Explore recruiting advanced relapsed clear cell renal cell carcinoma clinical trials.

Recruiting advanced relapsed clear cell renal cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Advanced Relapsed Clear Cell Renal Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Study of DFF332 alone and in combination with Everolimus or Immuno-oncology therapies in patients with renal cell carcinoma and other selected tumors.

Czechia, Spain, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Advanced Relapsed Clear Cell Renal Cell Carcinoma trials by city

Advanced Relapsed Clear Cell Renal Cell Carcinoma clinical trials

Recruiting advanced relapsed clear cell renal cell carcinoma studies right now

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Also recruiting in Europe

Study of DFF332 alone and in combination with Everolimus or Immuno-oncology therapies in patients with renal cell carcinoma and other selected tumors.

Advanced Relapsed Clear Cell Renal Cell Carcinoma trials by city

Other conditions